LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $98,000 | +44.1% | 10,640 | 0.0% | 0.00% | – |
Q1 2019 | $68,000 | -32.0% | 10,640 | 0.0% | 0.00% | – |
Q4 2018 | $100,000 | -54.8% | 10,640 | -3.1% | 0.00% | -100.0% |
Q3 2018 | $221,000 | -30.9% | 10,975 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $320,000 | -14.0% | 10,975 | -12.2% | 0.00% | 0.0% |
Q1 2018 | $372,000 | -14.3% | 12,500 | -7.4% | 0.00% | 0.0% |
Q4 2017 | $434,000 | – | 13,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 240,000 | $1,027,000 | 95.09% |
TANG CAPITAL MANAGEMENT LLC | 10,049,224 | $43,011,000 | 8.56% |
RTW INVESTMENTS, LP | 2,327,903 | $9,963,000 | 0.15% |
Boxer Capital, LLC | 890,700 | $3,812,000 | 0.13% |
Tibra Equities Europe Ltd | 72,600 | $311,000 | 0.10% |
WealthTrust Axiom LLC | 25,400 | $108,000 | 0.04% |
GSA CAPITAL PARTNERS LLP | 52,749 | $226,000 | 0.02% |
FIRST MIDWEST BANK TRUST DIVISION | 34,231 | $147,000 | 0.02% |
HOLLENCREST CAPITAL MANAGEMENT | 42,355 | $181,000 | 0.02% |
Summit Global Investments | 48,500 | $208,000 | 0.01% |